New York, New York--(Newsfile Corp. - December 1, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of common stock of Cepton, Inc. (NASDAQ: CPTN) between July 29, 2024 and January 6, 2025, both dates inclusive (the "Class Period"), of the important December 8, 2025 lead plaintiff deadline.SO WHAT: If you purchased or sold Cepton common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a c ...

Core Insights - Victory Square Technologies Inc. reported its financial results for Q3 and nine months ended September 30, 2025, highlighting significant developments across its various platforms, including digital health, biotech, pet wellness, climate tech, and immersive technology [1][4]. Financial Highlights - For Q3 2025, the company achieved adjusted revenue of $12.83 million and GAAP revenue of $10.52 million, with a gross margin of $2.33 million and adjusted EBITDA of $1.26 million [8]. - For the nine months ended September 30, 2025, adjusted revenue reached $26.71 million and GAAP revenue was $20.44 million [8]. Portfolio & Strategic Update - Hydreight Technologies, the flagship digital health subsidiary, continued to drive operational performance, recognized as one of the fastest-growing companies in North America [5][6]. - Hydreight's strategic positioning includes a focus on high-growth health segments such as GLP-1 therapies and hormone optimization, supported by a robust compliance infrastructure [10]. - The company launched a $10 million accelerator to incubate direct-to-consumer health companies scaling on the VSDHOne platform [16]. Digital Health Initiatives - Victory Square supports various digital health platforms, including telehealth and diagnostics, aimed at enhancing metabolic health, dermatology, and preventative health [13]. - The digital health market is experiencing increased adoption, with a projected U.S. healthcare spending reaching $7.2 trillion by 2031 [17]. Biotech and Pet Health Platforms - Insu Therapeutics is advancing its oral insulin tablet development, targeting first-in-human studies for 2026 [19][23]. - Pawsible Ventures launched a $10 million fund to accelerate innovation in pet health, aiming to support 15-20 companies over the next three years [19]. Immersive Technology - XR Immersive Tech is expanding into health-related intellectual property, focusing on digital health applications and patient education [20][24]. - Current development areas include digital twin models for chronic-condition tracking and immersive patient engagement tools [21][27]. Additional Notes - Victory Square manages a diversified portfolio of over 20 companies across various sectors, including digital health, AI, and climate tech [26][35]. - The company is actively reviewing monetization opportunities for non-core assets, including a recent Normal Course Issuer Bid allowing the repurchase of up to 5 million common shares [26].

Core Viewpoint - Rosen Law Firm is encouraging investors of Perrigo Company plc to secure legal counsel before the January 16, 2026 deadline for a securities class action lawsuit related to the company's performance during the specified class period [2][4]. Group 1: Class Action Details - The class period for the securities class action is from February 27, 2023, to November 4, 2025 [2]. - Investors who purchased Perrigo securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and potential lead plaintiffs must act by January 16, 2026 [4]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [5]. - Rosen Law Firm has a history of significant settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions for investors [5]. Group 3: Case Allegations - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business, including underinvestment in maintenance and significant manufacturing deficiencies [6]. - It is claimed that Perrigo's financial results were overstated due to these issues, leading to misleading positive statements about the company's operations and prospects [6].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of America's Car-Mart, Inc. due to allegations of materially misleading business information issued to the investing public [1]. Group 1: Legal Action and Investor Rights - Shareholders who purchased America's Car-Mart securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses [2]. Group 2: Company Performance and Market Reaction - On September 4, 2025, America's Car-Mart reported a first-quarter loss of $0.69 per share, compared to a net loss of $0.15 per share in the same period the previous year [3]. - Following the release of these results, America's Car-Mart's stock experienced a decline of 18.2% on the same day [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [4]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [4].

Core Viewpoint - Rosen Law Firm is encouraging investors of MoonLake Immunotherapeutics to secure legal counsel before the December 15, 2025 deadline for a securities class action lawsuit related to the company's stock performance during the specified class period [1][2]. Group 1: Class Action Details - Investors who purchased MoonLake common stock between March 10, 2024, and September 29, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - The lawsuit alleges that the defendants made false and misleading statements regarding the efficacy of their product SLK compared to traditional monoclonal antibodies, leading to investor damages when the truth was revealed [5]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - Rosen Law Firm has a history of successful settlements in securities class actions, including the largest settlement against a Chinese company and significant recoveries for investors in recent years [4].

Core Viewpoint - Molina Healthcare, Inc. is facing a securities class action lawsuit due to alleged failures in disclosing material adverse facts regarding its financial health and operational assumptions during the class period from February 5, 2025, to July 23, 2025 [2][6]. Group 1: Class Action Details - The Rosen Law Firm is encouraging investors who purchased Molina securities during the specified class period to secure legal counsel before the December 2, 2025, lead plaintiff deadline [2][4]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and potential lead plaintiffs must act by the deadline to represent other class members [4][8]. Group 2: Allegations Against Molina Healthcare - The lawsuit claims that Molina failed to disclose critical information, including adverse facts about its medical cost trend assumptions and the dislocation between premium rates and medical costs [6]. - It is alleged that Molina's near-term growth relied on a lack of utilization of various health services, which could lead to a significant cut in its financial guidance for fiscal year 2025 [6]. - The lawsuit asserts that the positive statements made by Molina regarding its business and prospects were materially misleading and lacked a reasonable basis [6]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked highly for settlements since 2013 [5]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for clients [5]. - The firm emphasizes the importance of selecting qualified counsel with a proven success record in leading securities class actions [5].

Core Viewpoint - The Rosen Law Firm is urging investors of Marex Group plc to secure legal counsel before the December 8, 2025 deadline for a securities class action lawsuit related to misleading financial statements and practices during the specified class period [1][5]. Group 1: Legal Action Details - Investors who purchased Marex securities between May 16, 2024, and August 5, 2025, may be eligible for compensation without upfront costs through a contingency fee arrangement [2]. - To participate in the class action, investors must act before the December 8, 2025 deadline to serve as lead plaintiff, representing other class members in the litigation [3]. Group 2: Rosen Law Firm's Credentials - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4]. - The firm has consistently ranked among the top firms for securities class action settlements, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. Group 3: Allegations Against Marex - The lawsuit alleges that Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements among subsidiaries [5]. - As a result of these actions, Marex's financial statements were deemed unreliable, leading to misleading positive statements about the company's business and operations [5].

New Stratus Energy Announces Results for the Three and Nine Months Ended September 30, 2025 & Corporate UpdatesDecember 01, 2025 8:33 PM EST | Source: New Stratus Energy Inc.Calgary, Alberta--(Newsfile Corp. - December 1, 2025) - New Stratus Energy Inc. (TSXV: NSE) ("New Stratus", "NSE" or the "Corporation") is pleased to announce the consolidated financial and operating results for the three and nine months ended September 30, 2025 that have been filed on SEDAR+ (www.sedarplus.ca).Three Month ...

Core Viewpoint - Trican Well Service Ltd. has approved a 2026 capital budget of $122 million, emphasizing its commitment to disciplined investment and long-term growth [1][3]. Capital Budget Overview - The approved capital budget focuses on maintenance capital to ensure reliability and efficiency across Trican's four divisions, while also allocating targeted growth capital for modernization initiatives [2][3]. - Approximately $40 million of the growth capital is designated for Canada's first 100% natural gas fueled, continuous, heavy-duty hydraulic fracturing fleet, expected to be field ready in the second half of 2026 [2]. Management Commentary - The President and CEO of Trican stated that the 2026 capital program reflects the company's commitment to disciplined investments that enhance service quality and position the company for long-term growth [3]. - The focus on maintenance and targeted growth initiatives aims to ensure reliable and efficient equipment, enabling Trican to capture future opportunities and deliver long-term value to customers and shareholders [3]. Company Background - Trican Well Service Ltd. is headquartered in Calgary, Alberta, and provides oil and natural gas well servicing equipment and solutions throughout the drilling, completion, and production cycles [4]. - The company offers state-of-the-art equipment, engineering support, reservoir expertise, and laboratory services, including hydraulic fracturing, cementing, coiled tubing, nitrogen services, and chemical sales for the oil and gas industry in Western Canada [4].

New York, New York--(Newsfile Corp. - December 1, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of StubHub Holdings, Inc. (NYSE: STUB) pursuant and/or traceable to the Registration Statement issued in connection with StubHub's September 2025 initial public offering (the "IPO"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 23, 2026 ...